Inventor · Lexington, MA, US

Bernhard J. Paul

18Patents
16h-index
16Co-inventors
71Inventor score

Filing activity: Apr 10, 2006 → Aug 11, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US7678770B2 Abuse-resistant amphetamine prodrugs Emerging Cross-Sectional Technologies 55 Active
US7671030B2 Abuse-resistant amphetamine prodrugs Emerging Cross-Sectional Technologies 54 Active
US7655630B2 Abuse-resistant amphetamine prodrugs Emerging Cross-Sectional Technologies 45 Active
US7662787B2 Abuse resistant lysine amphetamine compounds Emerging Cross-Sectional Technologies 43 Active
US7659253B2 Abuse-resistant amphetamine prodrugs Emerging Cross-Sectional Technologies 42 Active
US7700561B2 Abuse-resistant amphetamine prodrugs Emerging Cross-Sectional Technologies 40 Active
US7671031B2 Abuse-resistant amphetamine prodrugs Emerging Cross-Sectional Technologies 39 Active
US7674774B2 Abuse-resistant amphetamine prodrugs Emerging Cross-Sectional Technologies 39 Active
US7723305B2 Abuse-resistant amphetamine prodrugs Emerging Cross-Sectional Technologies 39 Active
US7718619B2 Abuse-resistant amphetamine prodrugs Emerging Cross-Sectional Technologies 39 Active
US7687466B2 Abuse-resistant amphetamine prodrugs Emerging Cross-Sectional Technologies 39 Active
US7678771B2 Abuse-resistant amphetamine prodrugs Emerging Cross-Sectional Technologies 39 Active
US7659254B2 Abuse-resistant amphetamine prodrugs Emerging Cross-Sectional Technologies 38 Active
US7687467B2 Abuse-resistant amphetamine prodrugs Emerging Cross-Sectional Technologies 25 Active
US7662788B2 Abuse-resistant amphetamine prodrugs Emerging Cross-Sectional Technologies 16 Active
US7713936B2 Abuse-resistant amphetamine prodrugs Emerging Cross-Sectional Technologies 16 Active
US11384116B2 Methods of making cholic acid derivatives and starting materials therefor Chemistry; Metallurgy 0 Active
US9815844B2 Pharmaceutically acceptable salts and polymorphic forms of hydrocodone benzoic acid enol ester and processes for making same Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.